Capital World Investors »

Royalty Pharma shares owned by Capital World Investors

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Capital World Investors from 13F filings

Historical chart of Capital World Investors investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Capital World Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Capital World Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $386M 8.0M 47.97

More positions owned by Capital World Investors

Broadcom (AVGO)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Philip Morris International (PM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)
Vertex Pharmaceuticals Incorporated (VRTX)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Amgen (AMGN)
Canadian Natural Resources (CNQ)

View all positions for Capital World Investors

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Adage Capital Partners GP
Swedbank AB
State Street Corporation
Vanguard Group
Capital World Investors
Geode Capital Management
Caledonia
Victory Capital Management
Vanguard Capital Management
Northern Trust

View all funds holding Royalty Pharma